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Background Advances in telemedicine may benefit patients with motor neurone disease/ 
amyotrophic lateral sclerosis (MND/ALS). Aims This study aimed to improve care 
through telemonitoring utilising standardised symptom monitoring, clinical 
measurements and assessment non-invasive ventilation (NIV) parameters. It was 
hypothesized that telemonitoring allows proactive intervention allowing symptom 
management and optimized ventilation indicated by adequate nocturnal SpO2 levels and 
minute ventilation (MV).  
Methods 13 ventilated patients (mean age=62yrs; median illness duration=14m; median 
NIV usage= 8m) were recruited. Previously developed questions monitored symptoms 
and NIV-related issues, generating alerts and interventions where required. Nocturnal 
pulse oximetry and the patient-ventilator interaction (PVI) data were collected weekly. A 
revised ALS functional rating scale (ALSFRS-R) was completed three-monthly. Given 
the sample size, Friedman's ANOVA and Spearman's correlation coefficient were used for 
analysis at the baseline, at 3 month, and at 6 month.  
Results In total, 137 alerts led to 62 interventions (direct review 13, treatment adjustment 
14, equipment provision 20, referral 15). Inspiratory positive airway pressure levels were 
increased median 16.8 and 21.9cmsH20 (Wk1 and 22), NIV adherence also increased 
over time (both p<.01). No change was observed with nocturnal SpO2 levels. ALSFRS-
R scores showed illness deteriorations. No consistent correlations were found between 
the variables.  
Conclusions This pilot study found telemonitoring to be beneficial in maintaining 
ventilation MND despite the illness deterioration. 
